Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Absci Corp (NQ: ABSI )

1.700 -0.110 (-6.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 730,669
Open 1.790
Bid (Size) 1.700 (41)
Ask (Size) 1.780 (3)
Prev. Close 1.810
Today's Range 1.631 - 1.820
52wk Range 1.130 - 7.040
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
From Absci Corporation
Via GlobeNewswire
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga

Performance

YTD
-24.78%
-24.78%
1 Month
+28.30%
+28.30%
3 Month
-15.00%
-15.00%
6 Month
-41.58%
-41.58%
1 Year
-49.85%
-49.85%

More News

Read More
Absci's Return On Capital Employed Insights
Via Benzinga
Absci Earnings Perspective: Return On Capital Employed
Via Benzinga
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
From Absci Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Via Benzinga
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
From Absci Corporation
Via GlobeNewswire
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Absci Corporation
Via GlobeNewswire
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the 43rd Annual Cowen Health Care Conference
From Absci Corporation
Via GlobeNewswire
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
From Absci Corporation
Via GlobeNewswire
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
From Absci Corporation
Via GlobeNewswire
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the Berenberg Discover AI Seminar
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the Piper Sandler Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci Reports Third Quarter 2022 Financial Results
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the Stifel Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Absci Welcomes Meta Senior Executive to Board of Directors
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.